Alison Vrbanac

5.2k total citations
16 papers, 518 citations indexed

About

Alison Vrbanac is a scholar working on Molecular Biology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Alison Vrbanac has authored 16 papers receiving a total of 518 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Infectious Diseases and 5 papers in Epidemiology. Recurrent topics in Alison Vrbanac's work include Gut microbiota and health (6 papers), Metabolomics and Mass Spectrometry Studies (3 papers) and Dermatology and Skin Diseases (3 papers). Alison Vrbanac is often cited by papers focused on Gut microbiota and health (6 papers), Metabolomics and Mass Spectrometry Studies (3 papers) and Dermatology and Skin Diseases (3 papers). Alison Vrbanac collaborates with scholars based in United States, Denmark and Canada. Alison Vrbanac's co-authors include Richard L. Gallo, Teruaki Nakatsuji, Rob Knight, James Sanford, Michael R. Williams, Victor Nizet, Chris Callewaert, Kathryn A. Patras, Pieter C. Dorrestein and Jennifer D. Hamilton and has published in prestigious journals such as Genome Research, The Journal of Infectious Diseases and The Annual Review of Pharmacology and Toxicology.

In The Last Decade

Alison Vrbanac

16 papers receiving 510 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alison Vrbanac United States 9 243 171 140 80 73 16 518
Sara K. B. Cassidy United States 4 332 1.4× 176 1.0× 130 0.9× 78 1.0× 73 1.0× 4 526
Seitaro Nakagawa Japan 9 188 0.8× 76 0.4× 143 1.0× 40 0.5× 40 0.5× 17 453
B. Capitanio Italy 16 518 2.1× 156 0.9× 91 0.7× 83 1.0× 46 0.6× 23 781
Sofie Marie Edslev Denmark 12 455 1.9× 279 1.6× 91 0.7× 71 0.9× 55 0.8× 32 591
S.‐W. Hong South Korea 5 60 0.2× 84 0.5× 245 1.8× 57 0.7× 72 1.0× 6 534
Cristina Lopes Portugal 9 96 0.4× 83 0.5× 218 1.6× 52 0.7× 54 0.7× 20 522
Vicente Navarro-López Spain 7 266 1.1× 58 0.3× 191 1.4× 32 0.4× 57 0.8× 8 433
Thilo Jakob Germany 11 204 0.8× 323 1.9× 55 0.4× 29 0.4× 99 1.4× 26 582
Maria Livia Bernardi Italy 14 147 0.6× 347 2.0× 80 0.6× 71 0.9× 90 1.2× 17 595
Sofía Sirvent Spain 14 205 0.8× 357 2.1× 97 0.7× 15 0.2× 132 1.8× 19 613

Countries citing papers authored by Alison Vrbanac

Since Specialization
Citations

This map shows the geographic impact of Alison Vrbanac's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison Vrbanac with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison Vrbanac more than expected).

Fields of papers citing papers by Alison Vrbanac

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison Vrbanac. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison Vrbanac. The network helps show where Alison Vrbanac may publish in the future.

Co-authorship network of co-authors of Alison Vrbanac

This figure shows the co-authorship network connecting the top 25 collaborators of Alison Vrbanac. A scholar is included among the top collaborators of Alison Vrbanac based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison Vrbanac. Alison Vrbanac is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Vrbanac, Alison, et al.. (2022). Human Milk Oligosaccharides Reduce Murine Group B Streptococcus Vaginal Colonization with Minimal Impact on the Vaginal Microbiota. mSphere. 7(1). e0088521–e0088521. 12 indexed citations
2.
Rajput, Akanksha, Saugat Poudel, Hannah Tsunemoto, et al.. (2021). Identifying the effect of vancomycin on health care–associated methicillin-resistant Staphylococcus aureus strains using bacteriological and physiological media. GigaScience. 10(1). 7 indexed citations
3.
4.
Mills, Robert H., Jacob M. Wozniak, Alison Vrbanac, et al.. (2020). Organ-level protein networks as a reference for the host effects of the microbiome. Genome Research. 30(2). 276–286. 5 indexed citations
5.
Jarmusch, Alan K., Alison Vrbanac, Jeremiah D. Momper, et al.. (2020). Enhanced Characterization of Drug Metabolism and the Influence of the Intestinal Microbiome: A Pharmacokinetic, Microbiome, and Untargeted Metabolomics Study. Clinical and Translational Science. 13(5). 972–984. 25 indexed citations
6.
Vrbanac, Alison, Kathryn A. Patras, Alan K. Jarmusch, et al.. (2020). Evaluating Organism-Wide Changes in the Metabolome and Microbiome following a Single Dose of Antibiotic. mSystems. 5(5). 10 indexed citations
7.
Callewaert, Chris, Teruaki Nakatsuji, Rob Knight, et al.. (2019). IL-4Rα Blockade by Dupilumab Decreases Staphylococcus aureus Colonization and Increases Microbial Diversity in Atopic Dermatitis. Journal of Investigative Dermatology. 140(1). 191–202.e7. 158 indexed citations
8.
Poudel, Saugat, Hannah Tsunemoto, Michael J. Meehan, et al.. (2019). Characterization of CA-MRSA TCH1516 exposed to nafcillin in bacteriological and physiological media. Scientific Data. 6(1). 43–43. 7 indexed citations
9.
Rajput, Akanksha, Saugat Poudel, Hannah Tsunemoto, et al.. (2019). Profiling the effect of nafcillin on HA-MRSA D712 using bacteriological and physiological media. Scientific Data. 6(1). 322–322. 6 indexed citations
10.
Callewaert, Chris, Rob Knight, Teruaki Nakatsuji, et al.. (2018). LB1505 Dupilumab-mediated IL-4Rα blockade decreases Staphylococcus aureus colonization and increases microbial diversity in patients with Atopic Dermatitis (AD). Journal of Investigative Dermatology. 138(9). B7–B7. 1 indexed citations
11.
Patras, Kathryn A., Mahmoud M. Al‐Bassam, Alison Vrbanac, et al.. (2018). Group B Streptococcus Biofilm Regulatory Protein A Contributes to Bacterial Physiology and Innate Immune Resistance. The Journal of Infectious Diseases. 218(10). 1641–1652. 36 indexed citations
12.
Vrbanac, Alison, Angelica M. Riestra, Alison Coady, et al.. (2018). The murine vaginal microbiota and its perturbation by the human pathogen group B Streptococcus. BMC Microbiology. 18(1). 197–197. 49 indexed citations
13.
Smelov, Vitaly, Alison Vrbanac, Marlies P. Noz, et al.. (2017). Chlamydia trachomatis Strain Types Have Diversified Regionally and Globally with Evidence for Recombination across Geographic Divides. Frontiers in Microbiology. 8. 2195–2195. 17 indexed citations
14.
Vrbanac, Alison, Justine W. Debelius, Lingjing Jiang, et al.. (2017). An Elegan(t) Screen for Drug-Microbe Interactions. Cell Host & Microbe. 21(5). 555–556. 2 indexed citations
15.
Vázquez‐Baeza, Yoshiki, Chris Callewaert, Justine W. Debelius, et al.. (2017). Impacts of the Human Gut Microbiome on Therapeutics. The Annual Review of Pharmacology and Toxicology. 58(1). 253–270. 61 indexed citations
16.
Williams, Michael R., Teruaki Nakatsuji, James Sanford, Alison Vrbanac, & Richard L. Gallo. (2016). Staphylococcus aureus Induces Increased Serine Protease Activity in Keratinocytes. Journal of Investigative Dermatology. 137(2). 377–384. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sara K. B. Cassidy Breakdown of academic impact, for papers by Seitaro Nakagawa Breakdown of academic impact, for papers by B. Capitanio Breakdown of academic impact, for papers by Sofie Marie Edslev Breakdown of academic impact, for papers by S.‐W. Hong Breakdown of academic impact, for papers by Cristina Lopes Breakdown of academic impact, for papers by Vicente Navarro-López Breakdown of academic impact, for papers by Thilo Jakob Breakdown of academic impact, for papers by Maria Livia Bernardi Breakdown of academic impact, for papers by Sofía Sirvent
Rankless by CCL
2026